Stories You Saw on Social

Eddie’s Story: Service, Survival, and the Clinical Trial That Changed Everything

New York Times: How an ‘Impossible’ Idea Led to a Pancreatic Cancer Breakthrough

Expanded Access Policy

NBC News: ‘A watershed moment’: A pancreatic cancer drug is set to transform treatment

John Squires: Embracing the Role of Caregiver

UNDERSTANDING BREAKTHROUGHS: A GUIDE TO THE PROGRESS PIPELINE

Revolution Medicines Statement on FDA Expanded Access Authorization for Daraxonrasib in Patients with Previously Treated Metastatic Pancreatic Cancer

A New Era in Pancreatic Cancer: How Personalized mRNA Vaccines are Changing What’s Possible

DONATE: New York City Walk for Research

A Turning Point in Pancreatic Cancer: Daraxonrasib

AACR Annual Meeting – DC01 – Where Expedited Pathways, Innovation, Safety, and Patient Access Collide: A KRAS Case Study

WATCH –
LustgartenLIVE! Understanding Early-Stage Clinical Trials: What Everyone Should Know

Daraxonrasib Demonstrates Unprecedented Overall Survival Benefit in Pivotal Phase 3 RASolute 302 Clinical Trial in Patients with Metastatic Pancreatic Cancer

New York Times: How Ben Sasse Is Living Now That He Is Dying

From Undruggable to Unstoppable: The State of KRAS Drug Development in Pancreatic Cancer

FCSP Foundation Dunk for a Cure

REGISTER: LustgartenLIVE! Understanding Early Stage Clinical Trials

Nature: The combination of a cancer vaccine, pembrolizumab, and stereotactic body radiation in patients with locally advanced pancreatic cancer: a single-arm, phase II study

PASS-01 Trial Publishes Landmark Results in the Journal of Clinical Oncology

Nature: Beta cell-derived cholecystokinin drives obesity-associated pancreatic adenocarcinoma development

Find a Walk Near You

WATCH | International Women’s Day: The Power of Persistence – Women Transforming Cancer Research and Care

Download the Active with Lustgarten App on Google Play

Download the Active with Lustgarten App on the App Store

Nature: How Congress can restore the independence of US science

Career Development Awards

The Lustgarten Equity, Accessibility, and Diversity (LEAD) Project

Sign up to Volunteer

The Oncologist: Computationally Assisted Patient Finding for Navigation to Optimize Pancreatic Cancer Care Access

Pancreatic cancer growth tied to cells’ self-eating process

Statement on the NHS–GRAIL Galleri Trial

“NATURE” – Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial

Lustgarten-Funded Discovery: Nerves Fuel Pancreatic Cancer Before Tumors Appear

The 2026 Edition of the Gustave Roussy Prize Awarded to Luis Diaz Jr., MD

Elizabeth M. Jaffee, MD, FAACR, and Antoni Ribas, MD, PhD, FAACR, Named New Editors-in-Chief of the AACR Journal Cancer Immunology Research

What Causes Pancreatic Cancer?

Finding Clinical Trials for Pancreatic Cancer

“Life is an Adventure” -Dr. Geena Bell

WATCH: LustgartenLIVE! Turning Hope into Expectations: Our Annual Year in Review and Outlook

New Report: ACS Cancer Facts & Figures 2026 report five-year relative survival rate for pancreatic cancer remains at 13%

2025: Led by Lustgarten Powered by YOU

Lustgarten-Funded Research Discovers the Body’s Natural Defense Against Pancreatic Cancer

Pancreatic Cancer Signs and Symptoms

Unlocking Early Detection: How Long-Term Investment Is Changing What’s Possible in Pancreatic Cancer

Progress fighting pancreatic cancer — one of the deadliest malignancies

New York Times: The U.S. Is Funding Fewer Grants in Every Area of Science and Medicine

The Heart of the Matter: Tatiana Schlossberg’s Battle for Truth

Pancreatic cancer trials fuel hope for new drug fast-tracked by FDA – The Washington Post

Three Ways Research Could Improve Pancreatic Cancer Treatment

The Latest Research from the 2025 AACR Special Conference

Remembering Michael Zinner, MD: A Visionary Leader and Cherished Friend

THE LUSTGARTEN FOUNDATION HONORS REVOLUTION MEDICINES FOR TRANSFORMATIVE RESEARCH IN PANCREATIC CANCER

WATCH: LustgartenLIVE! Lustgarten Sprint to Discovery

The Lustgarten Foundation Gathered Nation’s Foremost Pancreatic Cancer Experts for Annual Scientific Advisory Board Meeting

CBS New York Promo of the Long Island Walk for Research

Long Island grandmother gets new chance at life, thanks to pancreatic cancer clinical trials

NIH races to spend its 2025 grant money — but fewer projects win funding

Elicio Therapeutics Announces Investigator-Initiated Phase 1 Trial to be Conducted by Memorial Sloan Kettering Cancer Center and funded by The Lustgarten Foundation for Neoadjuvant ELI-002 7P in Pancreatic Ductal Adenocarcinoma

More than Two Decades of Honoring Mom

Take Action! Rally for Medical Research

Rally for Medical Research

The Lustgarten Foundation Announces Landmark Year of Fueling Cutting-Edge Pancreatic Cancer Research

NYT: Cancer Research At Risk

Standing Up for Science: 8 Powerful Ways to Protect Pancreatic Cancer Research

From CancerSEEK to Cancerguard™: How Early Research Sparked a New Era in Cancer Detection

22 Years and Counting | Alexis Ventre

Dr. Elizabeth Jaffee on Last Week Tonight with John Oliver

CROWN PRINCESS KATHERINE HOME IN BELGRADE AFTER TRIUMPH OVER CANCER

Linda Tantawi and Dr. Daniel King on Island Outlook

NYTimes: America First? Not When It Comes to Your Health

FIVECALLS: Calling your representative is the best way to make your voice heard

Find Your Representative

New KRAS-Targeting Vaccine Shows Promise in Preventing Pancreatic Cancer Recurrence

America Is Abandoning One of the Greatest Medical Breakthroughs

Clinical trials and research training stalled as billions in NIH funds sit idle

mRNA technology could hold hope for fighting cancer, but future is in doubt under RFK Jr.

Gavin DeGraw Performance – 2025 Stand Up to Cancer Telecast

2025 Stand Up to Cancer Telecast

Tell the Supreme Court: No Stay. Hands off NIH

FCSP Foundation’s 2025 Dunk for a Cure

Odds of winning NIH grants plummet as new funding policy and spending delays bite

Scientists Advance Efforts to Create ‘Virtual Cell Lab’ As Testing Ground for Future Research with Live Cells

Study Shows Pancreatic Cancer Screenings May Benefit People with Diabetes

CNN Health – World’s premier cancer institute faces crippling cuts and chaos

WATCH – Lustgarten LIVE! Vaccine Development | June 2025

Keeping Hope Alive | Sally Benson

Lustgarten Foundation Appoints New Board Member

CBS News: “When is Cancer Political?”

LF-Funded Discovery: Routine Blood Test Can Catch Cancer Years Sooner

Unlocking Immunotherapy: Insights from Lustgarten-Funded Leaders

CREW’s Findings of DOGE’s Cuts to Medical Research

The Lustgarten Foundation Receives $10 Million Gift from the Paul M. Angell Family Foundation

Celebrating a Family Patriarch | Mike Pasquale

Father’s Day Matching Donation

“New York Times” – The Disappearing Funds for
Chronic Diseases

Dash for Detection

Together, 1+1=5

NYT: The White House Gutted Science Funding. Now It Wants to ‘Correct’ Research.

Bringing a Victory Flag to Pancreatic Cancer | Tara Shanes-Knebel

2025 Career Development Awards Announced

AACR Calls on Congress to Summarily Reject the President’s FY2026 Budget Proposal for NIH

Trump administration cut $2.7 billion in NIH research funding through March, Senate committee minority report says

LF Funded Discovery – New immunotherapy target found in pancreatic cancer cells

TIME 100 Most Influential People in Health of 2025 | Vinod Balachandran, MD

THE LUSTGARTEN FOUNDATION HONORS REVOLUTION MEDICINES FOR TRANSFORMATIVE RESEARCH IN PANCREATIC CANCER

Trump’s Science Cuts Will Be Felt for Generations

CSHL: Lustgarten-Funded Discovery Promises to “Intercept” Pancreatic Cancer

Elizabeth Jaffee, MD, Feature in the Baltimore Banner

Silence Won’t Save Science

NIH Funding – Get Involved

2024 Annual Report

Recent Funding Challenges: Know the Facts

Social Media Toolkit

Current Funding Opportunities

Signs and Symptoms of Pancreatic Cancer